References
- Asadollahi R, Hyde CA, Zhong XY (2010). Epigenetics of ovarian cancer: from the lab to the clinic. Gynecol Oncol, 118, 81-7. https://doi.org/10.1016/j.ygyno.2010.03.015
- An J, Wei Q, Liu Z, et al (2010). Messenger RNA expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer-a case-control analysis. Int J Mol Epidemiol Genet, 1, 1-10.
- Costello JF, Frühwald MC, Smiraglia DJ, et al (2000). Aberrant CpG-island methylation has nonrandom and tumour-typespecific patterns. Nat Genet, 24, 132-8. https://doi.org/10.1038/72785
- Esteller M, Corn PG, Baylin SB, Herman JG (2001). A gene hypermethylation profile of human cancer. Cancer Re, 61, 3225-9.
- Hilton JL, Geisler JP, Rathe JA, et al (2002). Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst, 94, 1396-400. https://doi.org/10.1093/jnci/94.18.1396
- Holschneider CH, Berek JS (2000). Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol, 19, 3-10. https://doi.org/10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S
- Gudmundsdottir K, Ashworth A (2006). The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene, 25, 5864-74. https://doi.org/10.1038/sj.onc.1209874
- Jakubowska A, Gronwald J, Menkiszak J, et al (2007). Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat, 104, 299-308. https://doi.org/10.1007/s10549-006-9417-3
- Kanai Y, Hirohashi S (2007). Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis, 28, 2434-42. https://doi.org/10.1093/carcin/bgm206
- Lin J, Spitz MR, Wang Y, et al (2004). Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a casecontrol study. Carcinogenesis, 25, 1639-47. https://doi.org/10.1093/carcin/bgh175
- Motoyama N, Naka K (2004). DNA damage tumor suppressor genes and genomic instability. Curr Opin Genet Dev, 14, 11-6. https://doi.org/10.1016/j.gde.2003.12.003
- Olek A, Oswald J, Walter J (1996). A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res, 24, 5064-6. https://doi.org/10.1093/nar/24.24.5064
- Paige AJ (2003). Redefining tumour suppressor genes: exceptions to the two-hit hypothesis. Cell Mol Life Sci, 60, 2147-63. https://doi.org/10.1007/s00018-003-3027-6
- Permuth-Wey J, Sellers TA (2009). Epidemiology of ovarian cancer. Methods Mol Biol, 472, 413-37. https://doi.org/10.1007/978-1-60327-492-0_20
- Swisher EM, Gonzalez RM, Taniguchi T, et al (2009). Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas. Mol Cancer, 8, 48. https://doi.org/10.1186/1476-4598-8-48
- Varinderpal S (2004). Dhillon Mohd Shahid2 and Syed Akhtar Husain2 CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin. Molecular Cancer, 3, 33. https://doi.org/10.1186/1476-4598-3-33
- Widschwendter M, Berger J, Muller HM, Zeimet AG, Marth C (2001). Epigenetic downregulation of The retinoic acid receptor-beta2 gene in breast cancer. J Mammary Gland Biol Neoplasia, 6, 193-201. https://doi.org/10.1023/A:1011360724350
Cited by
- Aberrant Methylation of RASSF2A in Tumors and Plasma of Patients with Epithelial Ovarian Cancer vol.15, pp.3, 2014, https://doi.org/10.7314/APJCP.2014.15.3.1171
- Ascorbic acid improves pluripotency of human parthenogenetic embryonic stem cells through modifying imprinted gene expression in the Dlk1-Dio3 region vol.6, pp.1, 2015, https://doi.org/10.1186/s13287-015-0054-9
- Methylation Status and Expression of BRCA2 in Epithelial Ovarian Cancers in Indonesia vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8599
- Methylation status and protein expression of RASSF1A in endometriosis vol.11, pp.6, 2016, https://doi.org/10.3892/ol.2016.4512